Viewing Study NCT06449066



Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06449066
Status: RECRUITING
Last Update Posted: 2024-06-07
First Post: 2024-05-30

Brief Title: Primary Immunodeficiencies and Obstetrical Neuraxial Anaesthesia
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization: Assistance Publique - Hôpitaux de Paris

Study Overview

Official Title: Infectious Complications Associated With the Use of Peri-partum Neuraxial Anaesthesia in Patients With Primary Immunodeficiencies
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ANEU-DIP
Brief Summary: The purpose of this study is to evaluate if neuraxial anesthesia epidural or intradural anesthesia used during childbirth is associated with more frequent infectious complications in patients with primary immunodeficiencies PID
Detailed Description: Neuraxial anaesthesia epidural or intradural is often used to alleviate pain during labour and childbirth Although extremely efficient and safe rare but serious infectious complications such as epidural abscess or meningitis can occur afterwards

Patients with PID tend to have a greater risk of infectious complications than the general population With the progress of medical care in those pathologies female patients are now giving birth more often The use of neuraxial anaesthesia and the associated infectious complications have never been studied in this population

The investigators intend to review the medical records of PID patients who gave birth in an APHP hospital in the last 10 years to evaluate the use of neuraxial anesthesia and the frequency of infectious complications associated with neuraxial anesthesia

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None